BioStem Technologies, Inc. (BSEM)
OTCMKTS: BSEM · Delayed Price · USD
7.81
-0.14 (-1.76%)
May 31, 2024, 3:41 PM EDT - Market closed

Company Description

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.

Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally.

The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

BioStem Technologies, Inc.
Country United States
Founded 2014
Industry Biotechnology
Sector Healthcare
Employees 2
CEO Jason V. Matuszewski

Contact Details

Address:
2836 Center Port Circle
Pompano Beach, Florida 33604
United States
Phone 954-380-8342
Website biostemtechnologies.com

Stock Details

Ticker Symbol BSEM
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001658678
ISIN Number US0906842002
Employer ID 27-0400416

Key Executives

Name Position
Jason Matuszewski Chief Executive Officer, President, Director and Secretary
Michael Fortunato CPA Chief Financial Officer
Andrew Vanvurst Chief Operating Officer and Director
Dr. David M. Woynarowski Chief Medical Officer
Larry Jones Chief Revenue Officer
Dr. Irmgard Huber M.D. International Medical Advisor and Interim Chief Medical Officer
Shawn F. McCarrey Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 4, 2023 D Notice of Exempt Offering of Securities
May 25, 2021 D Notice of Exempt Offering of Securities
Aug 16, 2016 D Notice of Exempt Offering of Securities
Feb 1, 2016 D Notice of Exempt Offering of Securities